Premier Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-0.2	-0.05	-0.04	-0.4	-0.37	-0.4	-3.76	-1.77	-2.58	-1.41	Upgrade
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	Upgrade
Share-Based Compensation	0	0	0	0	0	0	0.78	0.11	1.85	0.75	Upgrade
Other Operating Activities	0.03	0.05	0.03	0.33	0.03	-0.05	2.47	1.17	0.27	0.02	Upgrade
Operating Cash Flow	-0.17	0	-0.01	-0.07	-0.34	-0.44	-0.51	-0.48	-0.46	-0.64	Upgrade
Capital Expenditures	0	0	0	0	-0	-0	-0	-0	0	-0	Upgrade
Investing Cash Flow	0	0	0	0	-0	-0	-0	-0	0	-0	Upgrade
Common Stock Issued	0.18	0	0.01	0	0	0.15	0.3	0.15	0	0.76	Upgrade
Other Financing Activities	-	-	-	-	0.33	0.3	0.27	0.33	0.4	-0.03	Upgrade
Financing Cash Flow	0.18	0	0.01	0	0.33	0.45	0.57	0.47	0.4	0.73	Upgrade
Net Cash Flow	0	0	0	-0.07	-0.02	0	0.06	-0.01	-0.07	0.09	Upgrade
Free Cash Flow	-0.17	0	-0.01	-0.07	-0.35	-0.45	-0.51	-0.49	-0.46	-0.64	Upgrade
Free Cash Flow Margin	-	-	-	-6986.95%	-2444.02%	-1123.02%	-1288.01%	-	-	-	Upgrade
Free Cash Flow Per Share	-0.00	0.00	-0.00	-0.00	-0.01	-0.13	-0.26	-200.81	-3.70	-7.86	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.